Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 254.42 million. The enterprise value is 243.93 million.

Market Cap	254.42M
Enterprise Value	243.93M

Important Dates

The last earnings date was Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Apr 25, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	11.40M

Valuation Ratios

The trailing PE ratio is 34.85.

PE Ratio	34.85
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	33.41
EV / Sales	5.99
EV / EBITDA	22.14
EV / EBIT	25.72
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.06.

Current Ratio	4.00
Quick Ratio	2.50
Debt / Equity	0.06
Debt / EBITDA	0.16
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.88% and return on invested capital (ROIC) is 18.68%.

Return on Equity (ROE)	24.88%
Return on Assets (ROA)	15.16%
Return on Invested Capital (ROIC)	18.68%
Return on Capital Employed (ROCE)	28.03%
Revenue Per Employee	261,959
Profits Per Employee	48,346
Employee Count	151
Asset Turnover	1.04
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.41% in the last 52 weeks. The beta is 0.76, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-2.41%
50-Day Moving Average	164.08
200-Day Moving Average	203.05
Relative Strength Index (RSI)	62.23
Average Volume (20 Days)	231

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 39.56 million and earned 7.30 million in profits. Earnings per share was 0.40.

Revenue	39.56M
Gross Profit	31.56M
Operating Income	9.22M
Pretax Income	9.44M
Net Income	7.30M
EBITDA	10.71M
EBIT	9.22M
Earnings Per Share (EPS)	0.40

Full Income Statement

Balance Sheet

The company has 12.60 million in cash and 1.76 million in debt, giving a net cash position of 10.84 million.

Cash & Cash Equivalents	12.60M
Total Debt	1.76M
Net Cash	10.84M
Net Cash Per Share	n/a
Equity (Book Value)	30.70M
Book Value Per Share	1.68
Working Capital	22.62M

Full Balance Sheet

Cash Flow

Operating Cash Flow	9.95M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.79%, with operating and profit margins of 23.30% and 18.46%.

Gross Margin	79.79%
Operating Margin	23.30%
Pretax Margin	23.86%
Profit Margin	18.46%
EBITDA Margin	27.07%
EBIT Margin	23.30%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 0.18%.

Dividend Per Share	0.33
Dividend Yield	0.18%
Dividend Growth (YoY)	-3.70%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	0.08%
Earnings Yield	2.87%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a